STI and HIV prevention at the pharmacy for young women
Part of Digestive system, Immune system & allergy, Infections clinical trials.
This study looks at making it easier for young women to get STI and HIV prevention services like PrEP (a daily pill to prevent HIV) when they pick up birth control at a retail pharmacy. It aims to see if offering these services in a pharmacy setting helps women access prevention more easily.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a cis-gender woman (you identify as a woman and were assigned female at birth).
- You are between 15 and 25 years old.
- You are looking to get birth control (like the pill, shot, implant, condoms, or emergency contraception) from a retail pharmacy.
- You are not currently taking PrEP (a daily medicine that helps prevent HIV).
- You are willing to be screened for PrEP, which includes an HIV test.
- You plan to stay in the area for the next 12 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the best ways to offer long-acting injectable PrEP (a shot to prevent HIV) in clinics. It involves clinic staff and a review of patient records to improve how this prevention option is delivered.
This study tests a program to help women at risk for HIV start and stay on PrEP, a daily pill that prevents HIV. It aims to see if the program helps women use PrEP effectively.
This study tests a program to help Black women decide whether to start PrEP (a daily pill that prevents HIV). It aims to make it easier to get PrEP and support your health.
This study looks at whether young women can get PrEP, a daily pill that prevents HIV, from local pharmacies instead of clinics. It aims to make it easier for adolescent girls and young women to start and continue PrEP in selected areas of Tanzania.
This study tests whether pharmacies can offer HIV prevention medications (PrEP/PEP) with remote nurse support. It aims to make HIV prevention easier to access in the community.
This trial studies whether giving the antibiotic doxycycline right after sex (known as Doxy-PEP) can prevent STIs. It asks participants to provide hair, blood, and urine samples and follow specific guidelines about hair and condom use.
Hear when a new Sexually Transmitted Infections (Not HIV or Hepatitis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.